DK2356218T3 - Fremgangsmåde og medium til neural differentiering af pluripotente celler - Google Patents

Fremgangsmåde og medium til neural differentiering af pluripotente celler Download PDF

Info

Publication number
DK2356218T3
DK2356218T3 DK09764840.6T DK09764840T DK2356218T3 DK 2356218 T3 DK2356218 T3 DK 2356218T3 DK 09764840 T DK09764840 T DK 09764840T DK 2356218 T3 DK2356218 T3 DK 2356218T3
Authority
DK
Denmark
Prior art keywords
cells
neural
medium
signaling pathway
pluripotent cells
Prior art date
Application number
DK09764840.6T
Other languages
English (en)
Inventor
Alexandra Benchoua
Anselme Perrier
Laetitia Aubry
Original Assignee
Inserm (Institut Nat De La Santé Et De La Rech Médicale)
Ass Francaise Contre Les Myopathies
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inserm (Institut Nat De La Santé Et De La Rech Médicale), Ass Francaise Contre Les Myopathies filed Critical Inserm (Institut Nat De La Santé Et De La Rech Médicale)
Application granted granted Critical
Publication of DK2356218T3 publication Critical patent/DK2356218T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0619—Neurons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0623—Stem cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5058—Neurological cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/32—Amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/36—Lipids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/38—Vitamins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/40—Nucleotides, nucleosides, bases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/15—Transforming growth factor beta (TGF-β)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/155—Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/16—Activin; Inhibin; Mullerian inhibiting substance
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/45—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biotechnology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)

Claims (12)

1. Kulturmedium omfattende: a) noggin eller fragmenter deraf, der inhiberer BMP-signalvejen; og b) en inhibitor af Transforming Growth Factor (TGF)/aktivin/nodal-signalvejen valgt fra gruppen bestående af SB431542, Lefty-A og Cerberus og fragmenter af Lefty-A og Cerberus, der inhiberer TGF/aktivin/nodal-signalvejen.
2. Kulturmedium ifølge krav 1, hvor kulturmediet yderligere omfatter : a) en kulstofkilde; b) essentielle aminosyrer; c) vitaminer: d) en purin og en pyrimidin; e) uorganiske salte; f) selenium; g) en antioxidant; h) en phospholipid prækursor; i) en unik fedtsyre; og j) et bærerprotein.
3. In vitro-fremgangsmåde til fremstilling afen population af neurale prækursorer, hvor fremgangsmåden omfatter trinnet at dyrke pluripotente celler med kulturmediet som defineret i et hvilket som helst af kravene 1 til 2.
4. In v/fro-fremgangsmåde ifølge krav 3, hvor de pluripotente celler er humane pluripotente celler.
5. In v/fro-fremgangsmåde ifølge krav 3 eller 4, hvor de pluripotente celler er stamceller.
6. In v/'tro-fremgangsmåde ifølge krav 5, hvor stamcellerne er embryonale stamceller.
7. In v/fro-fremgangsmåde ifølge krav 3 eller 4, hvor de pluripotente celler er inducerede pluripotente celler (IPS).
8. Kit til dyrkning af celler omfattende: a) noggin eller fragmenter deraf, der inhiberer BMP-signalvejen og b) en inhibitor af Transforming Growth Factor (TGF)/aktivin/nodal-signalvejen valgt fra gruppen bestående af SB431542, Lefty-A og Cerberus og fragmenter af Lefty-A og Cerberus, der inhiberer TGF/aktivin/nodal-signalvejen.
9. Kit til dyrkning af celler ifølge krav 8, yderligere omfattende en mediumbase.
10. In v/'fro-fremgangsmåde ifølge et hvilket som helst af kravene 3-7, hvor de pluripotente celler dyrkes med mediet som defineret i krav 1 eller 2 i mindst 5 dage.
11. In Wfro-fremgangsmåde ifølge et hvilket som helst af kravene 3-7, hvor de pluripotente celler dyrkes med mediet som defineret i krav 1 eller 2 i mindst 7 dage.
12. In vitro-fremgangsmåde ifølge et hvilket som helst af kravene 3-7, hvor de pluripotente celler dyrkes med mediet som defineret i krav 1 eller 2 i mindst 10 dage.
DK09764840.6T 2008-12-05 2009-12-07 Fremgangsmåde og medium til neural differentiering af pluripotente celler DK2356218T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08305887 2008-12-05
PCT/EP2009/066504 WO2010063848A1 (en) 2008-12-05 2009-12-07 Method and medium for neural differentiation of pluripotent cells

Publications (1)

Publication Number Publication Date
DK2356218T3 true DK2356218T3 (da) 2017-08-21

Family

ID=40427840

Family Applications (1)

Application Number Title Priority Date Filing Date
DK09764840.6T DK2356218T3 (da) 2008-12-05 2009-12-07 Fremgangsmåde og medium til neural differentiering af pluripotente celler

Country Status (6)

Country Link
US (3) US20110229441A1 (da)
EP (1) EP2356218B1 (da)
JP (1) JP5604766B2 (da)
DK (1) DK2356218T3 (da)
ES (1) ES2633935T3 (da)
WO (1) WO2010063848A1 (da)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8017395B2 (en) 2004-12-17 2011-09-13 Lifescan, Inc. Seeding cells on porous supports
US9080145B2 (en) 2007-07-01 2015-07-14 Lifescan Corporation Single pluripotent stem cell culture
EP2610336A1 (en) 2007-07-31 2013-07-03 Lifescan, Inc. Differentiation of human embryonic stem cells
US9062290B2 (en) 2007-11-27 2015-06-23 Lifescan, Inc. Differentiation of human embryonic stem cells
KR20190057164A (ko) 2008-02-21 2019-05-27 얀센 바이오테크 인코포레이티드 세포 부착, 배양 및 탈리를 위한 방법, 표면 개질 플레이트 및 조성물
CA2729121C (en) 2008-06-30 2019-04-09 Centocor Ortho Biotech Inc. Differentiation of pluripotent stem cells
CA2742268C (en) 2008-10-31 2020-02-18 Centocor Ortho Biotech Inc. Differentiation of human embryonic stem cells to the pancreatic endocrine lineage
MX2011004563A (es) 2008-10-31 2011-06-01 Centocor Ortho Biotech Inc Diferenciacion de celulas madre embrionarias humanas al linaje endocrino pancreatico.
CA2744227C (en) 2008-11-20 2018-10-02 Centocor Ortho Biotech Inc. Methods and compositions for cell attachment and cultivation on planar substrates
KR101837080B1 (ko) 2008-11-20 2018-03-09 얀센 바이오테크 인코포레이티드 마이크로-캐리어 상의 만능 줄기 세포 배양
US8642334B2 (en) 2009-02-17 2014-02-04 Memorial Sloan Kettering Cancer Center Methods of neural conversion of human embryonic stem cells
KR102058901B1 (ko) 2009-07-20 2019-12-24 얀센 바이오테크 인코포레이티드 인간 배아 줄기 세포의 분화
US11261425B2 (en) 2009-08-12 2022-03-01 Kyoto University Method for inducing differentiation of pluripotent stem cells into neural precursor cells
US10119120B2 (en) 2009-08-12 2018-11-06 Kyoto University Method for inducing differentiation of pluripotent stem cells into neural precursor cells
KR101168053B1 (ko) * 2009-11-06 2012-07-24 연세대학교 산학협력단 효율적이고 보편적인 전분화능 줄기세포의 신경세포 분화 유도방법
WO2011079017A2 (en) 2009-12-23 2011-06-30 Centocor Ortho Biotech Inc. Differentiation of human embryonic stem cells
EP2542667A4 (en) 2010-03-01 2013-07-31 Janssen Biotech Inc PROCESS FOR CLEANING CELLS OBTAINED FROM PLURIPOTENTIAL STEM CELLS
KR101903562B1 (ko) 2010-05-12 2018-10-02 얀센 바이오테크 인코포레이티드 인간 배아 줄기 세포의 분화
EP2412724A1 (en) * 2010-07-29 2012-02-01 Centre National de la Recherche Scientifique (C.N.R.S) Regulation of Glypican 4 activity to modulate the fate of stem cells and uses thereof
US20130149287A1 (en) 2010-07-30 2013-06-13 Cambridge Enterprise Limited Corticogenesis of Human Pluripotent Cells
US9181528B2 (en) 2010-08-31 2015-11-10 Janssen Biotech, Inc. Differentiation of pluripotent stem cells
EP2611909B1 (en) 2010-08-31 2018-01-17 Janssen Biotech, Inc. Differentiation of human embryonic stem cells
CN103154239B (zh) 2010-08-31 2018-05-15 詹森生物科技公司 人胚胎干细胞的分化
US9181529B2 (en) 2010-10-19 2015-11-10 Cellular Dynamics International, Inc. Titration of differentiation medium components
DK2694644T3 (da) 2011-03-30 2018-04-16 Cellular Dynamics Int Inc Priming af pluripotente stamceller til neural differentiering
US10280398B2 (en) 2011-11-04 2019-05-07 Memorial Sloan-Kettering Cancer Center Midbrain dopamine (DA) neurons for engraftment
CN105143446B (zh) 2011-12-22 2020-11-03 詹森生物科技公司 人胚胎干细胞分化成单一激素胰岛素阳性细胞
CN102604894B (zh) * 2012-02-29 2014-07-30 中国科学院广州生物医药与健康研究院 用于制备神经干细胞的培养基及其用途
CN104160018A (zh) 2012-03-07 2014-11-19 詹森生物科技公司 用于扩增和维持多能干细胞的成分确定的培养基
US20150064734A1 (en) * 2012-03-21 2015-03-05 Kyoto University Method for screening therapeutic and/or prophylactic agents for alzheimer's disease
RU2018108850A (ru) 2012-06-08 2019-02-26 Янссен Байотек, Инк. Дифференцировка эмбриональных стволовых клеток человека в панкреатические эндокринные клетки
WO2013187416A1 (ja) * 2012-06-12 2013-12-19 学校法人 慶應義塾 神経系分化に適したiPS細胞の増幅方法、及び神経幹細胞の誘導方法
US10370644B2 (en) 2012-12-31 2019-08-06 Janssen Biotech, Inc. Method for making human pluripotent suspension cultures and cells derived therefrom
US10138465B2 (en) 2012-12-31 2018-11-27 Janssen Biotech, Inc. Differentiation of human embryonic stem cells into pancreatic endocrine cells using HB9 regulators
DK2938724T3 (da) 2012-12-31 2020-12-14 Janssen Biotech Inc Dyrkning af humane embryonale stamceller ved luft-væskegrænsefladen til differentiering til endokrine pankreasceller
WO2014106141A1 (en) 2012-12-31 2014-07-03 Janssen Biotech, Inc. Suspension and clustering of human pluripotent cells for differentiation into pancreatic endocrine cells
EP2986716A1 (en) * 2013-04-15 2016-02-24 Institut National de la Santé et de la Recherche Médicale (INSERM) Method and medium for amplifying neural precursor cells
AU2014256876B2 (en) 2013-04-26 2020-11-12 Cornell, University Cortical interneurons and other neuronal cells produced by the directed differentiation of pluripotent and multipotent cells
SG10201500884WA (en) * 2014-02-05 2015-09-29 Agency Science Tech & Res Manufacture Of Vascular Smooth Muscle Cells And The Use
JP6588969B2 (ja) 2014-05-16 2019-10-09 ヤンセン バイオテツク，インコーポレーテツド 膵内分泌細胞内のｍａｆａ発現を強化するための小分子の使用
CN107208045B (zh) 2014-11-25 2018-11-02 宾州研究基金会 人神经胶质细胞转化成用于大脑和脊髓修复的神经细胞的化学重编程
SG11201707857VA (en) * 2015-03-30 2017-10-30 Ajinomoto Kk Chelated iron-containing culture medium for neural stem cells
MA45479A (fr) 2016-04-14 2019-02-20 Janssen Biotech Inc Différenciation de cellules souches pluripotentes en cellules de l'endoderme de l'intestin moyen
EP4328301A3 (en) 2016-08-16 2024-06-19 FUJIFILM Cellular Dynamics, Inc. Methods for differentiating pluripotent cells
US20210270813A1 (en) * 2018-06-28 2021-09-02 L'oreal Kit, method for screening an active compound in vitro and uses of a kit
KR102392133B1 (ko) 2019-09-25 2022-04-29 (주) 에스바이오메딕스 줄기세포로부터 도파민 신경전구세포 분화 유도 방법
US20240219375A1 (en) 2021-04-07 2024-07-04 FUJIFILM Cellular Dynamics, Inc. Dopaminergic precursor cells and methods of use
US20230014181A1 (en) * 2021-06-17 2023-01-19 Genentech, Inc. Culture system and methods for improved modeling of neurological conditions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003104444A1 (en) * 2002-06-05 2003-12-18 Es Cell International Pte Ltd Generation of neural stem cells from undifferentiated human embryonic stem cells
US20080089868A1 (en) * 2006-04-27 2008-04-17 The Research Foundation Of State University Of New York Retinal stem cell compositions and methods for preparing and using same
GB0622394D0 (en) * 2006-11-09 2006-12-20 Univ Cambridge Tech Differentiation of pluripotent cells
US8338170B2 (en) * 2008-04-21 2012-12-25 Viacyte, Inc. Methods for purifying endoderm and pancreatic endoderm cells derived from human embryonic stem cells

Also Published As

Publication number Publication date
US20110229441A1 (en) 2011-09-22
ES2633935T3 (es) 2017-09-26
US20180265843A1 (en) 2018-09-20
EP2356218B1 (en) 2017-05-03
EP2356218A1 (en) 2011-08-17
US20160160177A1 (en) 2016-06-09
WO2010063848A1 (en) 2010-06-10
JP2012510805A (ja) 2012-05-17
JP5604766B2 (ja) 2014-10-15

Similar Documents

Publication Publication Date Title
DK2356218T3 (da) Fremgangsmåde og medium til neural differentiering af pluripotente celler
US20230220335A1 (en) Methods for neural conversion of human embryonic stem cells
US11591567B2 (en) Specification of functional cranial placode derivatives from human pluripotent stem cells
US9796959B2 (en) Method for inducing astrocytes
EP1812556A2 (en) Neuronal progenitors from feeder-free human embryonic stem cell culture
CN105392881B (zh) 体细胞基于小分子转化为神经嵴细胞
WO2019093340A1 (ja) ナイーブ型多能性幹細胞からの原始内胚葉誘導方法
WO2021106765A1 (ja) ナイーブ型多能性幹細胞からの栄養外胚葉誘導方法
US11001803B2 (en) Method for generating neuronal and muscular cells
US20160053226A1 (en) Method and Medium for Amplifying Neural Precursor Cells
US20200362309A1 (en) Method for preparing BAP or BA cells
EP4381051A1 (en) Neural progenitor cells and therapeutic uses of same